BiotechTube
Adaptive Clinical Systems

Adaptive Clinical Systems

Princeton, United States· Est.
adaptive-clinical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $14.5M

Overview

Adaptive Clinical Systems is a private, revenue-generating technology company founded in 2010 and headquartered in Princeton, New Jersey. It operates in the Digital Health and AI/ML sectors, offering the Adaptive eClinical Bus® and Adaptive DataVIEW™ platforms to solve data fragmentation in clinical trials. The company's core value proposition is enabling true interoperability between disparate clinical systems (EDC, CTMS, eTMF, EHRs) through automated data integration, mapping, and validation, thereby streamlining trial operations. Its business model is a platform/services hybrid, partnering with a wide array of leading eClinical vendors to deliver integrated solutions to biotech sponsors and CROs.

Digital HealthAI / Machine Learning

Technology Platform

The Adaptive eClinical Bus® is an AI-enabled interoperability middleware platform that connects disparate clinical systems (EDC, CTMS, eTMF, EHR) via pre-built connectors. It features automated data integration, mapping, and FDA-compliant validation documentation generation. The Adaptive DataVIEW™ layer provides unified, interactive reporting and visualization from all connected data sources.

Funding History

2
Total raised:$14.5M
Series A$12M
Seed$2.5M

Opportunities

The rapid adoption of decentralized clinical trials (DCTs) and complex, multi-vendor technology stacks creates a pressing need for seamless data interoperability, driving demand for Adaptive's platform.
The industry's focus on operational efficiency and cost reduction aligns perfectly with the company's value proposition of automating manual data workflows and reducing study timelines.
Regulatory emphasis on data integrity and traceability further supports the need for its automated validation and audit trail capabilities.

Risk Factors

Competition from large, integrated eClinical suite vendors (e.g., Veeva, Medidata) who are improving their own interoperability features poses a significant threat.
The company's success depends on the continued performance and regulatory compliance of its core platform, where any failure in data security, system reliability, or validation processes could damage its reputation.
As a middleware provider, it is also vulnerable to changes in the API strategies of its key technology partners.

Competitive Landscape

Adaptive competes with large eClinical suite vendors (Veeva, Medidata, Oracle) that offer integrated but often walled-garden ecosystems, as well as other data aggregation and middleware startups focused on clinical trials. Its key differentiation is a vendor-agnostic, AI-powered platform focused solely on interoperability and automation, rather than displacing existing point solutions. The competitive landscape is intensifying as the value of unified clinical data becomes more widely recognized.

More companies in Digital Health & Biotech SaaS →More companies in United States →